Targeting G1–S Checkpoint Cancers with Cyclin Inhibitors
A groundbreaking study published in Nature unveils a novel strategy to exploit vulnerabilities in cancer cells defective in G1–S checkpoint ...
A groundbreaking study published in Nature unveils a novel strategy to exploit vulnerabilities in cancer cells defective in G1–S checkpoint ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine